Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,442 public trials 326 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Completed

A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation

NCT05918042

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Research Site Arkhangelsk, Russia
  • Research Site Barnaul, Russia
  • Research Site Chelyabinsk, Russia
  • Research Site Grozny, Russia
View all 24 locations
View Trial Details
Completed

The DIALOGUE Study: Swiss-Korean Billateral Collaboration

NCT04214210

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +19 more
Locations
  • HFR Fribourg - Hôpital cantonal Fribourg, Canton of Fribourg, Switzerland
  • Hirslanden Clinic Des Grangettes Geneva, Canton of Geneva, Switzerland
  • Hopital du Jura - Service d' Oncology Delémont, Canton of Jura, Switzerland
  • Kantonalspital Winterthur Winterthur, Canton of Zurich, Switzerland
View Trial Details
Completed

Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR

NCT04295577

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Royal United Hospitals Bath Bath, United Kingdom
  • Belfast Health & Social Care Trust Belfast, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • University Hospitals Bristol NHS Foundation Trust Bristol, United Kingdom
View all 15 locations
View Trial Details
Completed

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

NCT04354246

Conditions
Adnexal Diseases, Advanced Cancer, Blood Protein Disorders, +53 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
  • The Ohio State University Comprehensive Cancer Center. Columbus, Ohio, United States
View Trial Details
Completed

A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

NCT00959647

Conditions
Adnexal Diseases, Basal Cell Carcinoma, Carcinoma, +29 more
Locations
  • TGen Clinical Research Srvs Scottsdale, Arizona, United States
  • Children's Hospital Oakland, California, United States
  • Comprehensive Cancer Care Palm Springs, California, United States
  • Stanford Univ Medical Center Stanford, California, United States
View Trial Details
Completed

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

NCT03797326

Conditions
Adnexal Diseases, Advanced Solid Tumors, Astrocytoma, +49 more
Locations
  • City of Hope ( Site 0002) Duarte, California, United States
  • Cedars Sinai Medical Center ( Site 0003) Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center ( Site 0005) Sacramento, California, United States
  • University of Colorado, Anschutz Cancer Pavilion ( Site 0007) Aurora, Colorado, United States
View all 88 locations
View Trial Details
Completed

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

NCT03740165

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +22 more
Locations
  • University of Alabama at Birmingham (UAB) ( Site 0036) Birmingham, Alabama, United States
  • University of Arizona Cancer Center ( Site 0074) Tucson, Arizona, United States
  • Disney Family Cancer Center ( Site 0042) Burbank, California, United States
  • Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) Oakland, California, United States
View all 227 locations
View Trial Details

Related conditions